Cleared Traditional

MEDI-DYNE GUIDING CATHETER (K970401) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K970401 · Medi-Dyne, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
179d
Days
Class 2
Risk

K970401 is an FDA 510(k) clearance for the MEDI-DYNE GUIDING CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medi-Dyne, Inc. (Queensbury, US). The FDA issued a Cleared decision on August 1, 1997 after a review of 179 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medi-Dyne, Inc. devices

Submission Details

510(k) Number K970401 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 1997
Decision Date August 01, 1997
Days to Decision 179 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d slower than avg
Panel avg: 125d · This submission: 179d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 304
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K970401.
ENVOY AND VISTA BRITE TIP
K982632 · Cordis Corp. · Aug 1998
6F ENVOY GUIDING CATHETER
K982770 · Cordis Corp. · Aug 1998
VISTA BRITE TIP GUIDING CATHETERS
K972978 · Cordis Corp. · Oct 1997
VISTA BRITE TIP CATHETERS
K971572 · Cordis Corp. · Jul 1997
VISTA BRITE TIP CATHETERS
K963962 · Cordis Corp. · May 1997
VISTA BRITE TIP CATHETERS
K965211 · Cordis Corp. · Mar 1997